Clinical Trial Update: A Cohort Study on the Prevention of Nausea and Vomiting Induced by Concurrent Chemoradiotherapy for Lung Cancer Using Rolapitant and Palonosetron [NA]

View source ↗

Summary

This clinical trial update describes a prospective cohort study evaluating the combination of rolapitant and palonosetron to prevent nausea and vomiting in lung…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Palonosetron (palonosetron)
• Rolapitant (rolapitant)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Lung Cancer | NA | Status: NOT_YET_RECRUITING